Wesana Health Holdings Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Wesana Health Holdings has been growing earnings at an average annual rate of 27.9%, while the Pharmaceuticals industry saw earnings growing at 13.1% annually. Revenues have been declining at an average rate of 136.5% per year.
Anahtar bilgiler
27.9%
Kazanç büyüme oranı
67.1%
EPS büyüme oranı
| Pharmaceuticals Sektör Büyümesi | 7.3% |
| Gelir büyüme oranı | -136.5% |
| Özkaynak getirisi | n/a |
| Net Marj | n/a |
| Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Gelir ve Gider Dağılımı
Wesana Health Holdings nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -2 | 1 | 0 |
| 31 Mar 24 | 0 | -2 | 1 | 0 |
| 31 Dec 23 | 0 | -2 | 1 | 0 |
| 30 Sep 23 | 0 | -3 | 2 | 0 |
| 30 Jun 23 | 0 | 0 | 0 | 0 |
| 31 Mar 23 | 0 | -1 | 1 | 0 |
| 31 Dec 22 | 0 | -3 | 3 | 0 |
| 30 Sep 22 | 0 | -2 | 4 | 0 |
| 30 Jun 22 | 0 | -2 | 4 | 0 |
| 31 Mar 22 | 0 | -6 | 5 | 0 |
| 31 Dec 21 | 0 | -6 | 5 | 0 |
| 30 Sep 21 | 0 | -6 | 3 | 0 |
| 30 Jun 21 | 0 | -8 | 4 | 0 |
| 31 Mar 21 | 0 | -3 | 1 | 0 |
| 31 Dec 20 | 0 | 0 | 0 | 0 |
Kaliteli Kazançlar: DDX is currently unprofitable.
Büyüyen Kar Marjı: DDX is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: DDX is unprofitable, but has reduced losses over the past 5 years at a rate of 27.9% per year.
Büyüme Hızlandırma: Unable to compare DDX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: DDX is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (28.7%).
Özkaynak Getirisi
Yüksek ROE: DDX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.